Industries > Pharma > Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

PUBLISHED: 09 January 2013
PAGES: 157
PRODUCT CODE:
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

A myriad of pharmaceutical and diagnostic companies are now entering the highly attractive market of companion diagnostics, many of them entering into collaborations for developing a combination product. Apart from the well-known pharmaceutical and diagnostic companies, some small, niche-companies are also focusing on companion diagnostic development. At present, competition is largely dependent on the ability to collaborate with biotechnology and pharmaceutical companies to develop and commercialise these tests for their therapeutic drugs and drug candidates. The number of partnerships between the two industries will keep expanding as most pharmaceutical companies do not have an in-house diagnostic capability for either the development of a companion diagnostic or the commercialisation of the test once the drug is approved.

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023 analyses the top 12 companies involved in the companion diagnostics market. This report also provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are 125 tables and figures included. The result is a comprehensive market, and industry-centred study, with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global companion diagnostics market will reach $19.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

• 137 pages of comprehensive analysis
• 1 Exclusive Visiongain interviews with experts from-
– Myriad Genetics
• 125 tables, charts, and graphs
• Companion diagnostic market forecast between 2012-2023
• 2 companion diagnostic submarket forecasts from 2012-2023
– Theranostics
– Other companion diagnostics
• A SWOT analysis
• Several leading companies identified and 12 profiled –
Roche, Dako, QIAGEN, Abbott, Life Technologies, LabCorp, Genomic Health, MDxHealth, bioMerieux, Johnson and Johnson, Siemens and Myriad Genetics

You can order this report today

Gain an understanding of the overall companion diagnostics market and the leading companies operating in this market by ordering Top Companion Diagnostic Companies: Competitive Analysis 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Top Companion Diagnostic Companies: Competitive Analysis 2013-2023


Download sample pages

Complete the form below to download your free sample pages for Top Companion Diagnostic Companies: Competitive Analysis 2013-2023


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ